[Sinovac Raises $86.73 Million Through Private Placement Transaction · Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake in Sinovac After the Private Placement Transaction · Proceeds Will Be Used to Fund Improvement and Construction of Facilities for R&D Relating to Quality Con]
[W ashington FORM 8-A Amendment No. 4 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 15 Zhi Tong Road, Zhongguancun Science and Techno]
[W ashington FORM 8-A Amendment No. 4 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 15 Zhi Tong Road, Zhongguancun Science and Techno]
[Sinovac Raises $86.73 Million Through Private Placement Transaction · Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake in Sinovac After the Private Placement Transaction · Proceeds Will Be Used to Fund Improvement and Construction of Facilities for R&D Relating to Quality Con]
[Sinovac Files Motion for Summary Judgment on Rights Agreement in Delaware Chancery Court · The summary judgment motion asks the Delaware Court to ascertain whether a trigger event under its Rights Agreement has occurred · The Company recently obtained information demonstrating that the Sinobioway Co]
[Sinovac Files Motion for Summary Judgment on Rights Agreement in Delaware Chancery Court · The summary judgment motion asks the Delaware Court to ascertain whether a trigger event under its Rights Agreement has occurred · The Company recently obtained information demonstrating that the Sinobioway Co]
[SINOVAC BIOTECH RELAUNCHES COMPANY WEBSITE BEIJING, June 11, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the company has relaunched its website, . On April 30, 2018, the Company]
[SINOVAC BIOTECH RELAUNCHES COMPANY WEBSITE BEIJING, June 11, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the company has relaunched its website, . On April 30, 2018, the Company]
[Sinovac Files 2017 Annual Report on Form 20-F and Reports Unaudited Second Half, Audited Full Year 2017 Financial Results Filing of 2017 Annual Report www.sec.gov www.sinovac.com The Company has filed its 2017 Annual Report with the SEC on May 11, 2018. The 2017 Annual Report is available on the SEC]
[Sinovac Files 2017 Annual Report on Form 20-F and Reports Unaudited Second Half, Audited Full Year 2017 Financial Results Filing of 2017 Annual Report www.sec.gov www.sinovac.com The Company has filed its 2017 Annual Report with the SEC on May 11, 2018. The 2017 Annual Report is available on the SEC]
